Amiodarone use in patients listed for heart transplant is associated with increased 1-year post-transplant mortality

详细信息    查看全文

• 作者：Lauren B. Cooper ; MD ; MHS^a ; ^b ; ^{lauren.b.cooper@duke.edu} ; Robert J. Mentz ; MD^a ; ^b ; Leah B. Edwards ; PhD^c ; Amber R. Wilk ; PhD^c ; Joseph G. Rogers ; MD^a ; ^b ; Chetan B. Patel ; MD^a ; ^b ; Carmelo A. Milano ; MD^a ; ^d ; Adrian F. Hernandez ; MD ; MHS^a ; ^b ; Josef Stehlik ; MD ; MPH^e ; Lars H. Lund ; MD ; PhD^f
• 关键词：heart transplant ; pre-transplant ; graft dysfunction ; antiarrhythmics ; outcomes
• 刊名：The Journal of Heart and Lung Transplantation
• 出版年：2017
• 出版时间：February 2017
• 年：2017
• 卷：36
• 期：2
• 页码：202-210
• 全文大小：481 K
• 卷排序：36

文摘

Pre-transplant amiodarone use has been postulated as a risk factor for morbidity and mortality after orthotopic heart transplantation (OHT). We assessed pre-OHT amiodarone use and tested the hypothesis that it is associated with impaired post-OHT outcomes.MethodsWe performed a retrospective cohort analysis of adult OHT recipients from the registry of the International Society for Heart and Lung Transplantation (ISHLT). All patients had been transplanted between 2005 and 2013 and were stratified by pre-OHT amiodarone use. We derived propensity scores using logistic regression with amiodarone use as the dependent variable, and assessed the associations between amiodarone use and outcomes with Kaplan–Meier analysis after matching patients 1:1 based on propensity score, and with Cox regression with adjustment for propensity score.ResultsOf the 14,944 OHT patients in the study cohort, 32% (N = 4,752) received pre-OHT amiodarone. Amiodarone use was higher in recent years (29% in 2005 to 2007, 32% in 2008 to 2010, 35% in 2011 to 2013). Amiodarone-treated patients were older and more frequently had a history of sudden cardiac death (27% vs 13%) and pre-OHT mechanical circulatory support. Key donor characteristics and allograft ischemia times were similar between groups. In propensity-matched analyses, amiodarone-treated patients had higher rates of cardiac reoperation (15% vs 13%) and permanent pacemaker (5% vs 3%) after OHT and before discharge. Amiodarone-treated patients also had higher 1-year mortality (hazard ratio 1.15, 95% confidence interval 1.02 to 1.30), but the risks of early graft failure, retransplantation and rehospitalization were similar between groups.ConclusionsAmiodarone use before OHT was independently associated with increased 1-year mortality. The need for amiodarone therapy should be carefully and continuously assessed in patients awaiting OHT.